These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 1359451)

  • 1. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
    Robertson GS; Vincent SR; Fibiger HC
    Neuroscience; 1992 Jul; 49(2):285-96. PubMed ID: 1359451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.
    Robertson GS; Jian M
    Neuroscience; 1995 Feb; 64(4):1019-34. PubMed ID: 7753373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
    Le Moine C; Svenningsson P; Fredholm BB; Bloch B
    J Neurosci; 1997 Oct; 17(20):8038-48. PubMed ID: 9315922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
    Robertson GS; Staines WA
    Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons.
    Jian M; Staines WA; Iadarola MJ; Robertson GS
    Brain Res Mol Brain Res; 1993 Jul; 19(1-2):156-60. PubMed ID: 7689681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus.
    Brog JS; Zahm DS
    Neuroscience; 1996 Oct; 74(3):805-12. PubMed ID: 8884776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
    Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G
    Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.
    Svenningsson P; Fourreau L; Bloch B; Fredholm BB; Gonon F; Le Moine C
    Neuroscience; 1999 Mar; 89(3):827-37. PubMed ID: 10199616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons.
    Schiffmann SN; Vanderhaeghen JJ
    J Neurosci; 1993 Mar; 13(3):1080-7. PubMed ID: 7680065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus.
    Hoover BR; Marshall JF
    Neuroscience; 2002; 111(1):111-25. PubMed ID: 11955716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.
    Carta AR; Frau L; Pinna A; Morelli M
    Exp Neurol; 2010 Aug; 224(2):395-402. PubMed ID: 20452347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.